GlassScriptPhysician profile
Joanna Joy Glick
NPI 1821770546
$5,520.05
in general payments reported to CMS, 2019-2025
19 companies · $2,588 in 2025
The $2,588 reported for 2025 was more than what 97% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $614 · 2024: $2,318 · 2025: $2,588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,520.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,010.65 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $690.75 | 2023-2025 | Repatha, Repatha, Tepezza |
| Dexcom, INC. | $587.21 | 2023-2025 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $463.79 | 2024-2025 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $459.10 | 2023-2025 | Jardiance |
| Medtronic, INC. | $443.54 | 2024-2025 | Minimed 780g |
| Xeris Pharmaceuticals, INC. | $278.46 | 2024-2025 | Gvoke Hypopen, Recorlev |
| Insulet Corporation | $255.03 | 2023-2025 | Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $252.89 | 2023-2025 | |
| Sequel Med Tech, LLC | $206.77 | 2025 | Twiist |
| Lilly USA, LLC | $152.71 | 2024-2025 | Jardiance |
| Madrigal Pharmaceuticals | $150.00 | 2024 | Rezdiffra |
| Ascendis Pharma Endocrinology INC | $143.81 | 2025 | Yorvipath |
| Rhythm Pharmaceuticals, INC. | $124.99 | 2023 | |
| Tandem Diabetes Care, INC. | $121.68 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $65.38 | 2024 | |
| Esperion Therapeutics, INC. | $55.64 | 2024-2025 | Nexletol |
| Intuity Medical INC | $36.90 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Neurocrine Biosciences, INC. | $20.75 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanna Glick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.